-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
medicine
Medicine
The rapid development of a highly effective vaccine against SARS-CoV-2 is one of the greatest scientific achievements of the contemporary world
Argentina currently uses multiple vaccines against SARS-CoV-2, including the non-replicating adenovirus vaccine Sputnik V (Gamaleya Institute), ChAdOx1-S (Oxford-AstraZeneca) and Ad5-nCoV (CanSino); the mRNA vaccine BNT162b2 (Pfizer) and mRNA-1273 (Moderna); and the SARS-CoV-2 vaccine BBIBP-CorV (Sinopharm, Sinopharm) using an inactivated virus
This study showed that various heterologous vaccination regimens induced higher antibody responses than those induced by homologous regimens
▲